AbCellera Biologics Inc (NASDAQ:ABCL) currently has a daily average trading volume of 5.42M but it saw 8663641 shares traded in last market. With a market cap of 1.12B USD, the company’s current market price of $3.75 came rising about 7.45 while comparing to the previous closing price of $3.49. In past 52 weeks, the stock remained buoying in the range of price level as high as $4.09 and as low as $1.89. In the recent trading on the day, stock has struck highest price mark of $3.37 while lowest mark touched by it was $3.77.
The Benchmark Company upgraded its recommendation for the stock as a “Buy” from “Hold” on February 22, 2024 while assigning a price target of $9. KeyBanc Capital Markets issued its recommendations for the stock as it initiated the price target for the stock is $6.
Over the week, ABCL’s stock price is moving -1.32% down while it is 75.23% when we observe its performance for the past one month. Year-to-date it is 26.69% up and over the past year, the stock is showing an upside performance of 27.99%.
Currently, AbCellera Biologics Inc’s total number of outstanding shares is 298.36M with 22.97% of that held by the insiders while 44.79% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -15.45% and return on equity (ROE) at -15.59%. Stock’s beta reads 0.61. Stock has a price to book (P/B) ratio of 1.09 while price to sale or P/S ratio amounts to 48.41. Its return on asset (ROA) is -11.96% on average.
#
